Oxaliplatin + fluorouracil the new standard in colorectal cancer?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1521, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CT colonography: cost-effective screening for colorectal cancer?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Motesanib a new treatment approach for thyroid cancer?

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite

Do Older Adults Using NSAIDs Have a Reduced Risk of Colorectal Cancer?

By Hoffmeister Michael Chang-Claude Jenny Brenner Hermann

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 513-523

Adis International

Access to resources Recommend Favorite

Drug therapy + standard treatment adds value in prostate cancer?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 454, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite